Speaker illustration

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

Prof McMurray’s primary research interests are in heart failure, the cardiovascular consequences of diabetes and chronic kidney disease, atrial fibrillation and coronary heart disease, with a focus on clinical trials and epidemiology. He is, or was, the principal investigator, member of the executive committee or steering committee member in several large trials in his areas of interest. Professor McMurray served as the inaugural Eugene Braunwald Scholar in Cardiovascular Disease at the Brigham and Women’s Hospital, Boston, and visiting Professor of Medicine, Harvard University, Boston, Massachusetts USA 2010/2011. He is a Past-President of the Heart Failure Association of the ESC and is involved in guideline writing and the editorial boards of several leading journals. He is a Highly Cited Researcher (https://recognition.webofscience.com/awards/highly-cited/2021/) and has a H-index of >200 (https://scholar.google.com/citations?user=n0ZdRMoAAAAJ&hl=en).

Cardiotoxicity: how to organise patient care

Event: Heart Failure 2022

Topic: Cardio-Oncology

Session type: HowTo

Thumbnail

When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options

Event: Heart Failure 2022

Topic: Treatment

Session type: Satellite Symposium

Thumbnail

Congress committee e-posters choice in heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Congress Committee e-posters Choice

Thumbnail

Hot Line - GUIDE-HF

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Hot Line

Thumbnail

Hot Line - EMPEROR-Preserved / EMPEROR-Pooled

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Hot Line

Thumbnail

Improving Heart Failure outcomes: are we entering a new era of Heart Failure treatment?

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Treatment

Session type: Industry Q&A session

Thumbnail

Learning from DAPA-HF one year on: Expert on the spot

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Industry Live

Thumbnail

Heart failure treatment - Keeping the patient on the top of our mind

Event: ESC CONGRESS 2019

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

Meet the experts on getting to grips with HFpEF

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Satellite Symposium

Thumbnail

Treatment choices to optimise benefits for heart failure patients

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk